Heterologous BBIBP-CorV/ZF2001 vaccination augments neutralization against SARS-CoV-2 variants: A preliminary observation

MLA

Yingze Zhao, et al. “Heterologous BBIBP-CorV/ZF2001 Vaccination Augments Neutralization against SARS-CoV-2 Variants: A Preliminary Observation.” The Lancet Regional Health. Western Pacific, vol. 21, no. 100440-, Apr. 2022. EBSCOhost, https://doi.org/10.1016/j.lanwpc.2022.100440.

APA

Yingze Zhao, Xin Zhao, Rong Zhang, Beiwei Ye, Xiaoju Yuan, Danni Zhang, Lei Li, Jinmin Tian, Yaxin Guo, George F. Gao, & William J. Liu. (2022). Heterologous BBIBP-CorV/ZF2001 vaccination augments neutralization against SARS-CoV-2 variants: A preliminary observation. The Lancet Regional Health. Western Pacific, 21(100440-). https://doi.org/10.1016/j.lanwpc.2022.100440

Chicago

Yingze Zhao, Xin Zhao, Rong Zhang, Beiwei Ye, Xiaoju Yuan, Danni Zhang, Lei Li, et al. 2022. “Heterologous BBIBP-CorV/ZF2001 Vaccination Augments Neutralization against SARS-CoV-2 Variants: A Preliminary Observation.” The Lancet Regional Health. Western Pacific 21 (100440-). doi:10.1016/j.lanwpc.2022.100440.